Integer Holdings (ITGR) is preparing to report its Q4 earnings this Thursday morning, with analysts expecting a 2.9% year-over-year revenue growth to $462.7 million and adjusted earnings of $1.70 per share. The medical technology company met revenue expectations last quarter but missed full-year EBITDA and slightly missed revenue guidance. Despite some healthcare equipment and supplies peers underperforming, Integer Holdings’ stock is up 2.9% over the last month, heading into earnings with an average analyst price target of $85.57.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Integer Holdings (ITGR) Reports Q4: Everything You Need To Know Ahead Of Earnings
Integer Holdings (ITGR) is preparing to report its Q4 earnings this Thursday morning, with analysts expecting a 2.9% year-over-year revenue growth to $462.7 million and adjusted earnings of $1.70 per share. The medical technology company met revenue expectations last quarter but missed full-year EBITDA and slightly missed revenue guidance. Despite some healthcare equipment and supplies peers underperforming, Integer Holdings’ stock is up 2.9% over the last month, heading into earnings with an average analyst price target of $85.57.